Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Nanomed Diagnostics B V is currently managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This prosecution activity is assigned to 1 distinct examiner and is located within 1 distinct art unit. This structure indicates a highly focused examination process for the company's current intellectual property filings. The company's strategy appears to be concentrated on a specific technical area, which is reflected in the singular art unit assignment.
GREENE, CAROLYN LEE is designated as the busiest examiner for the portfolio, with 1 busiest examiner pending action. Because the total number of pending office actions is 1, this examiner is responsible for the company's entire active docket. This alignment between the pending action and the examiner simplifies the communication and strategy for the applicant.
The data shows that the company's current legal challenges are contained within 1 distinct art unit in the Biotechnology & Pharmaceuticals field. With only 1 pending office action to address, the company can dedicate its resources to the specific requirements of GREENE, CAROLYN LEE and the technical standards of the assigned art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GREENE, CAROLYN LEE | 1 | 65.7% | +46.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18497332 | Detection of Cancer in Urine | GREENE, CAROLYN LEE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18497332 | Detection of Cancer in Urine | GREENE, CAROLYN LEE | — |
| Art Unit | Apps |
|---|---|
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18497332 | Detection of Cancer in Urine | GREENE, CAROLYN LEE | 1681 | §102§103 | Final Rejection | — | Pending | Oct 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNanomed Diagnostics B V has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Carolyn Lee Greene has the most, with 1 of Nanomed Diagnostics B V's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
